🔗 Share this article

An underground economy for unapproved slimming drugs is propelled by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Experimental Treatment Gaining Popularity Online

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to message these accounts privately for supplier links, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where communities with thousands of members share “before and after” images, injection guides and assertions of next-day UK delivery. Vendors promote the substance there before directing customers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, physicians and pharmacists have warned that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to individuals injecting products of unknown origin.

Some experts said the demand for retatrutide could be connected to the increasing price of licensed slimming products such as Mounjaro.

Regulatory Status and Enforcement

Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.

Some content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to fines, legal action or prison.

Service Response and Material Removal

According to the social media company, the service has taken down problematic content and banned related keywords and query recommendations. The organization stated it was dedicated to keeping the service safe and investing in strengthening compliance measures.

Online Trading Operations

Research also found communities with up to nine thousand members marketing retatrutide using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately displays groups with numerous of members, filled with photos of slimming results, glowing testimonials and step-by-step instructions for preparing or administering at home.

Within minutes of entering one community, a vendor shared contact information, where most purchases occur. The seller sent an instruction manual and promised delivery within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about body mass, health issues or past usage.

Product Information and Costs

Within these communities, posts display dark colored packages with Royal Mail labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20 milligrams. When questioned how long a injector should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Service Moderation and Security Measures

A representative for the messaging service stated it regularly monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering materials they can’t verify. Even if the research behind retatrutide is valid, these digital versions may not include what they claim,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the surge in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, patients are turning to social media. But fake injections are highly risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.

Her team has previously encountered patients harmed by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company said the substance was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company investigational product not yet approved … may subject patients to potentially significant medical dangers”.